The cannabinoid WIN 55212-2 mitigates apoptosis and mitochondrial dysfunction after hypoxia ischemia.
about
Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.New horizons for newborn brain protection: enhancing endogenous neuroprotectionCannabinoids: well-suited candidates for the treatment of perinatal brain injury.Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.
P2860
The cannabinoid WIN 55212-2 mitigates apoptosis and mitochondrial dysfunction after hypoxia ischemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The cannabinoid WIN 55212-2 mi ...... nction after hypoxia ischemia.
@en
The cannabinoid WIN 55212-2 mi ...... nction after hypoxia ischemia.
@nl
type
label
The cannabinoid WIN 55212-2 mi ...... nction after hypoxia ischemia.
@en
The cannabinoid WIN 55212-2 mi ...... nction after hypoxia ischemia.
@nl
prefLabel
The cannabinoid WIN 55212-2 mi ...... nction after hypoxia ischemia.
@en
The cannabinoid WIN 55212-2 mi ...... nction after hypoxia ischemia.
@nl
P2093
P2860
P1476
The cannabinoid WIN 55212-2 mi ...... nction after hypoxia ischemia.
@en
P2093
D Alonso-Alconada
F J Alvarez
P2860
P2888
P304
P356
10.1007/S11064-011-0594-Z
P577
2011-09-11T00:00:00Z